Equity Capital Markets

Company · CIK 1861123

Eikon Therapeutics, Inc.

CIK1861123 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedEIKN (Nasdaq)
First annual or quarterly report2026-03-30

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-292633
IPOFinal prospectus
 2026-01-092026-02-054

Filings

5
FiledFilingRegistrationAccession
2026-02-05424B4Final prospectus 333-2926330001193125-26-039375
2026-01-30EFFECTDeclared effective 333-2926339999999995-26-000406
2026-01-28S-1/AAmendment 333-2926330001193125-26-025565
2026-01-09S-1Registration filed 333-2926330001193125-26-008888
2025-05-09DRSDraft made public 377-079900000950123-25-004458

All filings of this company · CSV